Puma Biotechnology director Wilson Troy Edward sold 5,000 shares at $9.10 each on Sept. 14. The transaction represented about 8.4% of his prior holding, while he retained 54,750 shares afterward, giving investors a precise view of the reported insider transaction and his remaining ownership.

Key Highlights

  • Wilson Troy Edward held 54,750 Puma Biotechnology shares after the transaction.
  • The sale represented about 8.4% of his prior Puma Biotechnology shareholding.
  • The transaction occurred on Sept. 14, 2026, under transaction code S.

PUMA BIOTECHNOLOGY, INC. (NASDAQ: PBYI) director Wilson Troy Edward sold 5,000 shares at $9.10 per share. The transaction took place on Sept. 14, 2026, and represents about 8.4% of his prior shareholding.

Sale Equals 8.4% of

Prior Holding The transaction represented about 8.4% of Wilson Troy Edward’s prior shares held in PUMA BIOTECHNOLOGY, INC. The reported post-transaction holding was 54,750 shares.